IMVAX.COM: Keyword Density Checker

Total words: 1036 | 2-word phrases: 272 | 3-word phrases: 285 | 4-word phrases: 288

PAGE INFO

Title	Try to keep the title under 60 characters (64 characters) Imvax » Turning the complexity of solid tumors against them
Description	Try to keep the meta description between 50 - 160 characters (109 characters) Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (53 characters) Turning the complexityof a solid tumor against itself

#	Keyword	Frequency	Density
1	lead program igv001	2	0.70%
2	clinical data in	2	0.70%
3	sno annual meeting	2	0.70%
4	2023 sno annual	2	0.70%
5	at 2023 sno	2	0.70%
6	read more november	2	0.70%
7	191062679004110 contactimvaxcom careers	1	0.35%
8	on lead program	1	0.35%
9	more november 10	1	0.35%
10	november 10 2023	1	0.35%
11	10 2023 imvax	1	0.35%
12	2023 imvax to	1	0.35%
13	present new data	1	0.35%
14	policy terms of	1	0.35%
15	privacy policy terms	1	0.35%
16	careers at imvax	1	0.35%
17	new data on	1	0.35%
18	contactimvaxcom careers at	1	0.35%
19	data on lead	1	0.35%
20	program igv001 at	1	0.35%
21	pa 191062679004110 contactimvaxcom	1	0.35%
22	igv001 at 2023	1	0.35%
23	read more about	1	0.35%
24	diagnosed glioblastoma read	1	0.35%
25	more about us	1	0.35%
26	about us culturecareers	1	0.35%
27	us culturecareers 601	1	0.35%
28	culturecareers 601 walnut	1	0.35%
29	601 walnut street	1	0.35%
30	walnut street suite	1	0.35%

#	Keyword	Frequency	Density
1	2023 sno annual meeting	2	0.69%
2	at 2023 sno annual	2	0.69%
3	include pieces of text	1	0.35%
4	completion of enrollment in	1	0.35%
5	of enrollment in phase	1	0.35%
6	enrollment in phase 2b	1	0.35%
7	in phase 2b clinical	1	0.35%
8	phase 2b clinical trial	1	0.35%
9	2b clinical trial of	1	0.35%
10	clinical trial of igv001	1	0.35%
11	trial of igv001 and	1	0.35%
12	to main content imvax	1	0.35%
13	successful financing read more	1	0.35%
14	these include pieces of	1	0.35%
15	of text that are	1	0.35%
16	financing read more november	1	0.35%
17	read more november 20	1	0.35%
18	more november 20 2023	1	0.35%
19	november 20 2023 imvax	1	0.35%
20	20 2023 imvax presents	1	0.35%
21	2023 imvax presents new	1	0.35%
22	identifiers these include pieces	1	0.35%
23	other identifiers these include	1	0.35%
24	data at 2023 sno	1	0.35%
25	pieces of text that	1	0.35%
26	skip to main content	1	0.35%
27	sno annual meeting supporting	1	0.35%
28	a diverse pipeline of	1	0.35%
29	glioblastoma and preclinical data	1	0.35%
30	and preclinical data in	1	0.35%
31	all rights reserved by	1	0.35%
32	data in multiple other	1	0.35%
33	in multiple other solid	1	0.35%
34	multiple other solid tumors	1	0.35%
35	other solid tumors imvax	1	0.35%
36	computer or device this	1	0.35%
37	is developing a diverse	1	0.35%
38	developing a diverse pipeline	1	0.35%
39	diverse pipeline of personalized	1	0.35%
40	21 2024 imvax announces	1	0.35%

#	URL	Whois	Check
1	https://www.linkedin.com/company/imvax-inc/	Whois	linkedin.com
2	https://twitter.com/imvax_inc	Whois	twitter.com